Nonmyeloablative Conditioning Does Not Prevent Telomere Shortening after Allogeneic Stem Cell Transplantation
暂无分享,去创建一个
A. Nagler | A. Fraser | M. Szyper-Kravitz | I. Hardan | M. Lahav | Meir Kestenbaum | H. Shapiro | J. Radnay | O. Uziel | N. Shem-Tov | Shimoni Avihai | M. Szyper‐Kravitz
[1] A. Smogorzewska,et al. Regulation of telomerase by telomeric proteins. , 2004, Annual review of biochemistry.
[2] A. Nagler,et al. Clinical Implications of Minimal Residual Disease Monitoring for Stem Cell Transplantation after Reduced Intensity and Nonmyeloablative Conditioning , 2004, Acta Haematologica.
[3] K. Moore,et al. Stem cells: Interactive niches , 2003, Nature.
[4] I. Weissman,et al. Telomerase is required to slow telomere shortening and extend replicative lifespan of HSCs during serial transplantation. , 2003, Blood.
[5] J. Bourhis,et al. Therapy‐related myelodysplasia and/or acute myeloid leukaemia after autologous haematopoietic progenitor cell transplantation in a prospective single centre cohort of 221 patients , 2003, British journal of haematology.
[6] S. Cho,et al. Telomere length shortening in non-Hodgkin's lymphoma patients undergoing chemotherapy , 2003, Annals of Hematology.
[7] A. Nagler,et al. Intravenous busulfan-based conditioning prior to allogeneic hematopoietic stem cell transplantation: myeloablation with reduced toxicity. , 2003, Experimental hematology.
[8] T. Spitzer. The expanding applications of non‐myeloablative stem cell transplantation , 2003, Pediatric transplantation.
[9] I. Weissman,et al. Effect of TERT over-expression on the long-term transplantation capacity of hematopoietic stem cells , 2003, Nature Medicine.
[10] W. Hahn,et al. Erosion of the telomeric single-strand overhang at replicative senescence , 2003, Nature Genetics.
[11] R. Storb,et al. Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissio , 2003, Blood.
[12] M. Lishner,et al. Granulocyte colony‐stimulating factor administration upregulates telomerase activity in CD34+ haematopoietic cells and may prevent telomere attrition after chemotherapy , 2003, British journal of haematology.
[13] P. Lansdorp,et al. Telomere shortening in hematopoietic stem cell transplantation: a potential mechanism for late graft failure? , 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[14] R. DePinho,et al. Connecting chromosomes, crisis, and cancer. , 2002, Science.
[15] John Doyle,et al. Early hematopoietic reconstitution after clinical stem cell transplantation: evidence for stochastic stem cell behavior and limited acceleration in telomere loss. , 2002, Blood.
[16] J. Campisi,et al. Telomeres, aging and cancer: In search of a happy ending , 2002, Oncogene.
[17] S. Ackland,et al. Telomere Length in Haemopoietic Stem Cells can be Determined from that of Mononuclear Blood Cells or Whole Blood , 2002, Leukemia & lymphoma.
[18] A. Multani,et al. Human bone marrow transplant rejection is associated with telomere cleavage. , 2001, International journal of molecular medicine.
[19] S. Shin,et al. Different onsets of oxidative damage to DNA and lipids in bone marrow and liver in rats given total body irradiation. , 2001, Free radical biology & medicine.
[20] R. Cancedda,et al. High‐dose chemotherapy shows a dose‐dependent toxicity to bone marrow osteoprogenitors , 2001, Cancer.
[21] Margaret A. Strong,et al. The Shortest Telomere, Not Average Telomere Length, Is Critical for Cell Viability and Chromosome Stability , 2001, Cell.
[22] R. Nowak,et al. Wiedemann-Rautenstrauch (neonatal progeroid) syndrome: new case with normal telomere length in skin fibroblasts. , 2001, American journal of medical genetics.
[23] A. Jauch,et al. Alternative lengthening of telomeres is associated with chromosomal instability in osteosarcomas , 2001, Oncogene.
[24] T. Brümmendorf,et al. Limited Telomere Shortening in Hematopoietic Stem Cells after Transplantation , 2001, Annals of the New York Academy of Sciences.
[25] N. Russell,et al. Accelerated telomere shortening following allogeneic transplantation is independent of the cell source and occurs within the first year post transplant , 2001, Bone Marrow Transplantation.
[26] G. Wisman,et al. Human Telomere Length in Breast Cancer Patients before and after Chemotherapy with or without Stem Cell Transplantation , 2000 .
[27] I. Weissman,et al. Telomere Shortening Accompanies Increased Cell Cycle Activity during Serial Transplantation of Hematopoietic Stem Cells , 2001, The Journal of experimental medicine.
[28] R. Cancedda,et al. Bone Marrow Stromal Damage after Chemo/Radiotherapy: Occurrence, Consequences and Possibilities of Treatment , 2001, Leukemia & lymphoma.
[29] T. Brümmendorf,et al. Polyclonal hematopoiesis with variable telomere shortening in human long-term allogeneic marrow graft recipients. , 2000, Blood.
[30] P. Mcgale,et al. Telomere length shortening in chronic myelogenous leukemia is associated with reduced time to accelerated phase. , 2000, Blood.
[31] M. Urashima,et al. Shortening of telomeres in recipients of both autologous and allogeneic hematopoietic stem cell transplantation , 2000, Bone Marrow Transplantation.
[32] M. Freedman,et al. Telomere shortening in leucocyte subsets of long‐term survivors of allogeneic bone marrow transplantation , 1999, British journal of haematology.
[33] Lynda Chin,et al. E.: “A Summary of , 1968 .
[34] K. Ohyashiki,et al. Telomere stability is frequently impaired in high-risk groups of patients with myelodysplastic syndromes. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[35] R. Effros. Replicative senescence in the immune system: impact of the Hayflick limit on T-cell function in the elderly. , 1998, American journal of human genetics.
[36] J. Shay. Accelerated telomere shortening in bonemarrow recipients , 1998, The Lancet.
[37] T. Dexter,et al. Accelerated telomere shortening in young recipients of allogeneic bone-marrow transplants , 1998, The Lancet.
[38] A. Cimmino,et al. In vivo telomere dynamics of human hematopoietic stem cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[39] B L Levine,et al. Human naive and memory T lymphocytes differ in telomeric length and replicative potential. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[40] E. Rogaev,et al. Telomere shortening is associated with cell division in vitro and in vivo. , 1995, Experimental cell research.
[41] C B Harley,et al. Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[42] H. Deeg,et al. Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia. , 1989, The New England journal of medicine.
[43] J. Abrams,et al. Increased exhaled nitric oxide following autologous peripheral hematopoietic stem-cell transplantation: a potential marker of idiopathic pneumonia syndrome. , 2004, Chest.
[44] D. Broccoli,et al. Measurable immune dysfunction and telomere attrition in long-term allogeneic transplant recipients , 2004, Bone Marrow Transplantation.
[45] A. Nagler,et al. Nonmyeloablative stem cell transplantation: lessons from the first decade of clinical experience. , 2004, Current hematology reports.
[46] H. Tanke,et al. Homeostasis of telomere length rather than telomere shortening after allogeneic peripheral blood stem cell transplantation. , 2003, Blood.
[47] T. von Zglinicki. Oxidative stress shortens telomeres. , 2002, Trends in biochemical sciences.
[48] Chimerism testing and detection of minimal residual disease after allogeneic hematopoietic transplantation using the Duet™ (BioView) combined morphological and cytogenetical analysis , 2002, Leukemia.
[49] R. Childs,et al. Nonmyeloablative stem cell transplantation for solid tumors: expanding the application of allogeneic immunotherapy. , 2002, Seminars in hematology.
[50] A. Nagler,et al. Chimerism testing and detection of minimal residual disease after allogeneic hematopoietic transplantation using the bioView (Duet™) combined morphological and cytogenetical analysis , 2002, Leukemia.
[51] A. Nagler,et al. Non-myeloablative stem cell transplantation (NST): chimerism testing as guidance for immune-therapeutic manipulations , 2001, Leukemia.
[52] D. Blaise,et al. Allogeneic peripheral blood stem cell transplantation results in less alteration of early T cell compartment homeostasis than bone marrow transplantation , 2001, Bone Marrow Transplantation.
[53] P. Lansdorp,et al. Telomere length dynamics in human lymphocyte subpopulations measured by flow cytometry , 1998, Nature Biotechnology.
[54] M. Engelhardt,et al. Telomerase activity and telomere length in pediatric patients with malignancies undergoing chemotherapy , 1998, Leukemia.
[55] Wei Han,et al. Telomerase regulation, cell cycle, and telomere stability in primitive hematopoietic cells. , 1997, Blood.